July 13, 2022, on the same day COSELA®( trilaciclib hydrochloride for injection), the worlds first comprehensive myeloprotection drug against ...

On July 13 2022, Simcere Pharmaceuticals (02096.HK) announced that the China National Medical Products Administration (NMPA) has conditionally approve...

On June 13, 2022, Simcere Pharma (2096.HK) announced that a global multi-center pivotal Phase 3 clinical trial (PRESERVE1 study) of Trilaciclib, an in...

The 2022 annual meeting of American Society of Clinical Oncology (ASCO) held in Chicago and online in June 3-7, 2022 (EST) is attracting global attent...